Tricia A Moo-Young
Affiliation: Washington University School of Medicine
- Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancerTricia A Moo-Young
Laboratory for Biologic Cancer Therapy, Department of Surgery, Washington University School of Medicine, Saint Louis, MO 63110, USA
J Immunother 32:12-21. 2009..Collectively, these observations further support the role of TGF-beta in the induction of Treg in pancreas adenocarcinoma...
- Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinomaUdaya K Liyanage
Laboratory for Biologic Cancer Therapy, Department of Surgery and Alvin J Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO, USA
J Immunother 29:416-24. 2006..We conclude that Pan02 tumor promotes the prevalence of Treg, in part through the secretion of TGF-beta, which may result in immune evasion...
- Timing of Adjuvant Radioactive Iodine Therapy Does Not Affect Overall Survival in Low- and Intermediate-Risk Papillary Thyroid CarcinomaParitosh Suman
Department of Surgery, NorthShore University Health System University of Chicago, Evanston, Illinois, USA
Am Surg 82:807-14. 2016..98, 95% confidence interval = 0.71-1.34, P = 0.887). In conclusion, the timing of postthyroidectomy adjuvant RAI therapy does not affect OS in low- or intermediate-risk PTC. ..
- Sporadic and familial medullary thyroid carcinoma: state of the artTricia A Moo-Young
Department of Surgery, Washington University School of Medicine, St Louis, MO 63110, USA
Surg Clin North Am 89:1193-204. 2009..New systemic therapies for metastatic disease are being investigated. Targeted molecular therapies, based on knowledge of the pathways affected by RET mutations, are being tested in multiple clinical trials...